Review the Research<\/p>\n
Get summaries of key research on vitamin D and COVID-19<\/h5><\/div><\/div><\/div><\/div><\/div>\nThe Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study<\/span><\/span>\u00a0<\/span><\/h1><\/div>Take Home Message<\/span><\/h2><\/div><\/div><\/div><\/div><\/div><\/div>Results<\/span><\/h2><\/div><\/div><\/div>\n- No statistically significant was shown for ICU admission [Odd Ratio, OR 1.25 (95% confidence interval, CI 0.41\u20133.88) p = 0.70], M<\/span>echanical <\/span>V<\/span>entilation<\/span> support [Odd Ratio, OR 3.12 (95% confidence interval, CI 0.74\u201313.21) p = 0.12] and mortality [Odd Ratio, OR 2.39 (95% confidence interval, CI 0.31\u201318.11), p = 0.40].<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div>
![](\"https:\/\/www.vitamindandme.org\/wp-content\/uploads\/2022\/08\/Bushnaq111-300x200.jpg\" "\\"Old")
<\/span><\/div><\/div><\/div><\/div><\/div>Who<\/span><\/h2><\/div>1<\/span>97 COVID-19 <\/span>patients<\/span> admitted at King Faisal Hospital, Al Noor Specialist Hospital in Makkah, and at Complex King Faisal Hospital in Taif in the Westering region of Saudi Arabia (SA) between June and August <\/span>2020.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Things to Keep in Mind<\/span><\/h2><\/div>\n- This is a small retrospective study using just 197 subjects. Selection bias may impact results<\/span>\u00a0<\/span><\/li>\n
- The researchers adjusted for certain confounders such as age, gender and diabetes mellitus type 2 (DM), hypertension, and chronic kidney disease (CKD). However, not all potential confounders were controlled for<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
\n- Whether or not a patient had received supplementation was not considered<\/span>\u00a0<\/span><\/li>\n
- This was only studied in one country, Saudi Arabia<\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>
Author\u2019s Conclusions<\/span><\/h2><\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div>In conclusion, the prevalence of vitamin D deficiency is high among COVID-19 patients in the Western region of SA. The lack of association was detected in the present study between serum vitamin D and severity of COVID-19, including ICU admission, intubation, mortality, and days of hospitalization. Further <\/span>large randomized<\/span> control tail studies covering multiple institutions are needed to determine the therapeutic effect of vitamin D supplementation on COVID-19 severity<\/span><\/p>\n<\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div><\/div><\/div>Study Design<\/span><\/h2><\/div>\n- This was a<\/span> retrospective, multicenter observational study<\/span> conducted to investigate<\/span> the impact of vitamin D status on the severity of hospitalized COVID-19 patients in terms of intensive care unit (ICU) admission, Mechanical Ventilation (MV) support, length of hospital stays, and mortality in the Western region of S<\/span>audi <\/span>A<\/span>rabia<\/span>.<\/span><\/li>\n<\/ul>\n
\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Reference<\/span><\/h2><\/div>Bushnaq<\/span> T, <\/span>Algethami<\/span> F, Qadhi A, et al.<\/span> The Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study. Int J Environ Res Public Health. 2022;19(3):1901. Published 2022 Feb 8. doi:10.3390\/ijerph19031901<\/span><\/p>\n<\/div><\/div><\/div>
The Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study<\/span><\/span>\u00a0<\/span><\/h1><\/div>Take Home Message<\/span><\/h2><\/div><\/div><\/div><\/div><\/div><\/div>Results<\/span><\/h2><\/div><\/div><\/div>\n- No statistically significant was shown for ICU admission [Odd Ratio, OR 1.25 (95% confidence interval, CI 0.41\u20133.88) p = 0.70], M<\/span>echanical <\/span>V<\/span>entilation<\/span> support [Odd Ratio, OR 3.12 (95% confidence interval, CI 0.74\u201313.21) p = 0.12] and mortality [Odd Ratio, OR 2.39 (95% confidence interval, CI 0.31\u201318.11), p = 0.40].<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>
Who<\/span><\/h2><\/div>1<\/span>97 COVID-19 <\/span>patients<\/span> admitted at King Faisal Hospital, Al Noor Specialist Hospital in Makkah, and at Complex King Faisal Hospital in Taif in the Westering region of Saudi Arabia (SA) between June and August <\/span>2020.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Things to Keep in Mind<\/span><\/h2><\/div>\n- This is a small retrospective study using just 197 subjects. Selection bias may impact results<\/span>\u00a0<\/span><\/li>\n
- The researchers adjusted for certain confounders such as age, gender and diabetes mellitus type 2 (DM), hypertension, and chronic kidney disease (CKD). However, not all potential confounders were controlled for<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
\n- Whether or not a patient had received supplementation was not considered<\/span>\u00a0<\/span><\/li>\n
- This was only studied in one country, Saudi Arabia<\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>
Author\u2019s Conclusions<\/span><\/h2><\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div>In conclusion, the prevalence of vitamin D deficiency is high among COVID-19 patients in the Western region of SA. The lack of association was detected in the present study between serum vitamin D and severity of COVID-19, including ICU admission, intubation, mortality, and days of hospitalization. Further <\/span>large randomized<\/span> control tail studies covering multiple institutions are needed to determine the therapeutic effect of vitamin D supplementation on COVID-19 severity<\/span><\/p>\n<\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div><\/div><\/div>Study Design<\/span><\/h2><\/div>\n- This was a<\/span> retrospective, multicenter observational study<\/span> conducted to investigate<\/span> the impact of vitamin D status on the severity of hospitalized COVID-19 patients in terms of intensive care unit (ICU) admission, Mechanical Ventilation (MV) support, length of hospital stays, and mortality in the Western region of S<\/span>audi <\/span>A<\/span>rabia<\/span>.<\/span><\/li>\n<\/ul>\n
\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Reference<\/span><\/h2><\/div>Bushnaq<\/span> T, <\/span>Algethami<\/span> F, Qadhi A, et al.<\/span> The Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study. Int J Environ Res Public Health. 2022;19(3):1901. Published 2022 Feb 8. doi:10.3390\/ijerph19031901<\/span><\/p>\n<\/div><\/div><\/div>
Take Home Message<\/span><\/h2><\/div><\/div><\/div><\/div><\/div><\/div>Results<\/span><\/h2><\/div><\/div><\/div>\n- No statistically significant was shown for ICU admission [Odd Ratio, OR 1.25 (95% confidence interval, CI 0.41\u20133.88) p = 0.70], M<\/span>echanical <\/span>V<\/span>entilation<\/span> support [Odd Ratio, OR 3.12 (95% confidence interval, CI 0.74\u201313.21) p = 0.12] and mortality [Odd Ratio, OR 2.39 (95% confidence interval, CI 0.31\u201318.11), p = 0.40].<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>
Who<\/span><\/h2><\/div>1<\/span>97 COVID-19 <\/span>patients<\/span> admitted at King Faisal Hospital, Al Noor Specialist Hospital in Makkah, and at Complex King Faisal Hospital in Taif in the Westering region of Saudi Arabia (SA) between June and August <\/span>2020.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Things to Keep in Mind<\/span><\/h2><\/div>\n- This is a small retrospective study using just 197 subjects. Selection bias may impact results<\/span>\u00a0<\/span><\/li>\n
- The researchers adjusted for certain confounders such as age, gender and diabetes mellitus type 2 (DM), hypertension, and chronic kidney disease (CKD). However, not all potential confounders were controlled for<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
\n- Whether or not a patient had received supplementation was not considered<\/span>\u00a0<\/span><\/li>\n
- This was only studied in one country, Saudi Arabia<\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>
Author\u2019s Conclusions<\/span><\/h2><\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div>In conclusion, the prevalence of vitamin D deficiency is high among COVID-19 patients in the Western region of SA. The lack of association was detected in the present study between serum vitamin D and severity of COVID-19, including ICU admission, intubation, mortality, and days of hospitalization. Further <\/span>large randomized<\/span> control tail studies covering multiple institutions are needed to determine the therapeutic effect of vitamin D supplementation on COVID-19 severity<\/span><\/p>\n<\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div><\/div><\/div>Study Design<\/span><\/h2><\/div>\n- This was a<\/span> retrospective, multicenter observational study<\/span> conducted to investigate<\/span> the impact of vitamin D status on the severity of hospitalized COVID-19 patients in terms of intensive care unit (ICU) admission, Mechanical Ventilation (MV) support, length of hospital stays, and mortality in the Western region of S<\/span>audi <\/span>A<\/span>rabia<\/span>.<\/span><\/li>\n<\/ul>\n
\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Reference<\/span><\/h2><\/div>Bushnaq<\/span> T, <\/span>Algethami<\/span> F, Qadhi A, et al.<\/span> The Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study. Int J Environ Res Public Health. 2022;19(3):1901. Published 2022 Feb 8. doi:10.3390\/ijerph19031901<\/span><\/p>\n<\/div><\/div><\/div>
Results<\/span><\/h2><\/div><\/div><\/div>\n- No statistically significant was shown for ICU admission [Odd Ratio, OR 1.25 (95% confidence interval, CI 0.41\u20133.88) p = 0.70], M<\/span>echanical <\/span>V<\/span>entilation<\/span> support [Odd Ratio, OR 3.12 (95% confidence interval, CI 0.74\u201313.21) p = 0.12] and mortality [Odd Ratio, OR 2.39 (95% confidence interval, CI 0.31\u201318.11), p = 0.40].<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>
Who<\/span><\/h2><\/div>1<\/span>97 COVID-19 <\/span>patients<\/span> admitted at King Faisal Hospital, Al Noor Specialist Hospital in Makkah, and at Complex King Faisal Hospital in Taif in the Westering region of Saudi Arabia (SA) between June and August <\/span>2020.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Things to Keep in Mind<\/span><\/h2><\/div>\n- This is a small retrospective study using just 197 subjects. Selection bias may impact results<\/span>\u00a0<\/span><\/li>\n
- The researchers adjusted for certain confounders such as age, gender and diabetes mellitus type 2 (DM), hypertension, and chronic kidney disease (CKD). However, not all potential confounders were controlled for<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
\n- Whether or not a patient had received supplementation was not considered<\/span>\u00a0<\/span><\/li>\n
- This was only studied in one country, Saudi Arabia<\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>
Author\u2019s Conclusions<\/span><\/h2><\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div>In conclusion, the prevalence of vitamin D deficiency is high among COVID-19 patients in the Western region of SA. The lack of association was detected in the present study between serum vitamin D and severity of COVID-19, including ICU admission, intubation, mortality, and days of hospitalization. Further <\/span>large randomized<\/span> control tail studies covering multiple institutions are needed to determine the therapeutic effect of vitamin D supplementation on COVID-19 severity<\/span><\/p>\n<\/div><\/div><\/div>“<\/span><\/h2><\/div><\/div><\/div><\/div><\/div>Study Design<\/span><\/h2><\/div>\n- This was a<\/span> retrospective, multicenter observational study<\/span> conducted to investigate<\/span> the impact of vitamin D status on the severity of hospitalized COVID-19 patients in terms of intensive care unit (ICU) admission, Mechanical Ventilation (MV) support, length of hospital stays, and mortality in the Western region of S<\/span>audi <\/span>A<\/span>rabia<\/span>.<\/span><\/li>\n<\/ul>\n
\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>Reference<\/span><\/h2><\/div>Bushnaq<\/span> T, <\/span>Algethami<\/span> F, Qadhi A, et al.<\/span> The Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study. Int J Environ Res Public Health. 2022;19(3):1901. Published 2022 Feb 8. doi:10.3390\/ijerph19031901<\/span><\/p>\n<\/div><\/div><\/div>
- \n
- No statistically significant was shown for ICU admission [Odd Ratio, OR 1.25 (95% confidence interval, CI 0.41\u20133.88) p = 0.70], M<\/span>echanical <\/span>V<\/span>entilation<\/span> support [Odd Ratio, OR 3.12 (95% confidence interval, CI 0.74\u201313.21) p = 0.12] and mortality [Odd Ratio, OR 2.39 (95% confidence interval, CI 0.31\u201318.11), p = 0.40].<\/span><\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/span><\/div><\/div><\/div><\/div><\/div>
Who<\/span><\/h2><\/div>
1<\/span>97 COVID-19 <\/span>patients<\/span> admitted at King Faisal Hospital, Al Noor Specialist Hospital in Makkah, and at Complex King Faisal Hospital in Taif in the Westering region of Saudi Arabia (SA) between June and August <\/span>2020.<\/span><\/span>\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>
Things to Keep in Mind<\/span><\/h2><\/div>
- \n
- This is a small retrospective study using just 197 subjects. Selection bias may impact results<\/span>\u00a0<\/span><\/li>\n
- The researchers adjusted for certain confounders such as age, gender and diabetes mellitus type 2 (DM), hypertension, and chronic kidney disease (CKD). However, not all potential confounders were controlled for<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
- \n
- Whether or not a patient had received supplementation was not considered<\/span>\u00a0<\/span><\/li>\n
- This was only studied in one country, Saudi Arabia<\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>
Author\u2019s Conclusions<\/span><\/h2><\/div><\/div><\/div>
“<\/span><\/h2><\/div><\/div><\/div>
In conclusion, the prevalence of vitamin D deficiency is high among COVID-19 patients in the Western region of SA. The lack of association was detected in the present study between serum vitamin D and severity of COVID-19, including ICU admission, intubation, mortality, and days of hospitalization. Further <\/span>large randomized<\/span> control tail studies covering multiple institutions are needed to determine the therapeutic effect of vitamin D supplementation on COVID-19 severity<\/span><\/p>\n<\/div><\/div><\/div>
“<\/span><\/h2><\/div><\/div><\/div><\/div><\/div>
Study Design<\/span><\/h2><\/div>
- \n
- This was a<\/span> retrospective, multicenter observational study<\/span> conducted to investigate<\/span> the impact of vitamin D status on the severity of hospitalized COVID-19 patients in terms of intensive care unit (ICU) admission, Mechanical Ventilation (MV) support, length of hospital stays, and mortality in the Western region of S<\/span>audi <\/span>A<\/span>rabia<\/span>.<\/span><\/li>\n<\/ul>\n
\u00a0<\/span><\/p>\n<\/div><\/div><\/div><\/div><\/div>
Reference<\/span><\/h2><\/div>
Bushnaq<\/span> T, <\/span>Algethami<\/span> F, Qadhi A, et al.<\/span> The Impact of Vitamin D Status on COVID-19 Severity among Hospitalized Patients in the Western Region of Saudi Arabia: A Retrospective Cross-Sectional Study. Int J Environ Res Public Health. 2022;19(3):1901. Published 2022 Feb 8. doi:10.3390\/ijerph19031901<\/span><\/p>\n<\/div><\/div><\/div>
- This was only studied in one country, Saudi Arabia<\/span>\u00a0<\/span><\/li>\n<\/ul>\n<\/div><\/div><\/div><\/div><\/div>
- The researchers adjusted for certain confounders such as age, gender and diabetes mellitus type 2 (DM), hypertension, and chronic kidney disease (CKD). However, not all potential confounders were controlled for<\/span>\u00a0<\/span><\/li>\n<\/ul>\n
- This is a small retrospective study using just 197 subjects. Selection bias may impact results<\/span>\u00a0<\/span><\/li>\n